Browse Stroke (Emergency Medicine)
Case 12-2022: A 41-Year-Old Woman with Transient Ischemic Attack and Mitral Valve Masses
N Engl J Med 2022; 386:1560-1570A 41-year-old woman with transient dysarthria and facial droop was evaluated for mitral valve masses. Three weeks earlier, she had heavy vaginal bleeding with crampy abdominal pain, fatigue, and lightheadedness. CT imaging was notable for small chronic cerebral infarcts and uterine fibroids. Diagnostic test results were received, and management decisions...
- EditorialVOL. 386 No. 14, Apr 07, 2022
In Stroke, When Is a Good Outcome Good Enough?
N Engl J Med 2022; 386:1359-1361In this issue of the Journal, Yoshimura and colleagues1 report the favorable results of a well-conducted randomized trial comparing mechanical thrombectomy (endovascular therapy) with medical care in patients with large-vessel occlusion and large cerebral infarctions. Previous trials of endovascular therapy in selected populations of patients with...
- Images in Clinical MedicineVOL. 386 No. 14, Apr 07, 2022
Thrombectomy in Acute Ischemic Stroke
N Engl J Med 2022; 386:1351-1351A 63-year-old man presented with weakness on the left side and difficulty speaking, both of which had begun 6 hours earlier. Imaging revealed a complete occlusion of the right internal carotid artery. He received emergency endovascular therapy.
- Original ArticleVOL. 386 No. 14, Apr 07, 2022
Endovascular Therapy for Acute Stroke with a Large Ischemic Region
N Engl J Med 2022; 386:1303-1313Endovascular therapy for stroke is generally avoided if the cerebral infarction is large. In a trial conducted in Japan, the percentage of patients who had a good functional outcome at 90 days was higher with endovascular therapy than with medical care, but there were more cerebral hemorrhages with endovascular therapy.
- Original ArticleVOL. 385 No. 27, Dec 30, 2021
Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA
N Engl J Med 2021; 385:2520-2530In a trial in China, patients with a minor stroke or transient ischemic attack with CYP2C19 loss-of-function alleles as determined by point-of-care testing had modestly fewer second strokes with ticagrelor than with clopidogrel but also had more total bleeding events.
Case 40-2021: A 9-Year-Old Boy with Transient Weakness, Facial Droop, and Slurred Speech
N Engl J Med 2021; 385:2563-2572A 9-year-old boy was transferred to this hospital because of transient weakness, facial droop, and slurred speech that occurred after an episode of crying. The symptoms lasted approximately 2 minutes and then resolved. Two years earlier, the patient had been evaluated for episodes of shaking in the arms and legs....
- EditorialVOL. 385 No. 27, Dec 30, 2021
Genetic Profile–Guided Therapy for Stroke?
N Engl J Med 2021; 385:2576-2577The late 20th and early 21st centuries have seen a reduction in stroke risk resulting from lifestyle changes such as widespread smoking cessation and more regular exercise, advances in the treatment of hypertension and hyperlipidemia, and better control of the vascular complications of diabetes.1 Antiplatelet agents have played...
- EditorialVOL. 385 No. 20, Nov 11, 2021
Alteplase and Thrombectomy — Not a Bridge to Dismantle
N Engl J Med 2021; 385:1904-1905In the past few years, thrombectomy — the removal of a thrombus under angiographic guidance — has become an accepted treatment for acute ischemic stroke caused by occlusion of a large cerebral vessel.1 Guidelines have included the use of intravenous alteplase preceding thrombectomy1 if there are...
- Original ArticleVOL. 385 No. 20, Nov 11, 2021
A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke
N Engl J Med 2021; 385:1833-1844Trials involving Asian patients with acute stroke have suggested that endovascular treatment alone is not inferior to the usual practice of thrombolysis before endovascular treatment. This trial involving European patients did not show noninferiority or superiority of endovascular treatment alone.
- EditorialVOL. 385 No. 11, Sep 09, 2021
Does My District Need a Mobile Stroke Unit?
N Engl J Med 2021; 385:1043-1044In their article in this issue of the Journal on emergency medical response in cases of stroke, Grotta and colleagues1 report several positive findings for mobile stroke units in comparison with conventional medical service ambulances. These include 22% greater access to intravenous thrombolysis treatment with mobile...
- Original ArticleVOL. 385 No. 11, Sep 09, 2021
Prospective, Multicenter, Controlled Trial of Mobile Stroke Units
N Engl J Med 2021; 385:971-981Mobile stroke units have CT scanners and personnel trained to administer tissue plasminogen activator. In a multicity trial, functional outcomes at 90 days after acute stroke were better with mobile stroke units than with standard care by emergency medical services and transfer to an emergency department.
- EditorialVOL. 384 No. 20, May 20, 2021
Endovascular Therapy for Basilar-Artery Occlusion — Still Waiting for Answers
N Engl J Med 2021; 384:1954-1955The benefits of endovascular therapy provided soon after the onset of acute ischemic stroke due to large-vessel occlusion in the proximal anterior cerebral circulation were established by five clinical trials, the results of which were published in 2015.1 The DAWN (DWI or CTP Assessment with Clinical Mismatch in...
- Original ArticleVOL. 384 No. 20, May 20, 2021
Endovascular Therapy for Stroke Due to Basilar-Artery Occlusion
N Engl J Med 2021; 384:1910-1920In a randomized trial involving 300 patients with basilar-artery stroke, endovascular thrombectomy was not significantly different from medical therapy with respect to a favorable functional outcome (modified Rankin scale score of 0 to 3) at 90 days, but a clinically significant benefit could not be excluded.
- CorrespondenceVOL. 384 No. 10, Mar 11, 2021
Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke
N Engl J Med 2021; 384:970-971In the initial report of the Gore REDUCE trial of patent foramen ovale closure, with a median follow-up of 3.2 years, 18 patients had stroke recurrence (6 in the PFO closure group and 12 in the antiplatelet-only group). After a median follow-up of 5 years, 20 patients had stroke recurrence,...
- Original ArticleVOL. 383 No. 3, Jul 16, 2020
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA
N Engl J Med 2020; 383:207-217A trial involving 11,016 patients showed that the combination of ticagrelor and aspirin after a stroke or high-risk transient ischemic attack was better than aspirin alone in preventing a stroke or death within 30 days. Severe bleeding was rare but occurred more frequently in the dual antiplatelet group.
- Clinical PracticeVOL. 383 No. 3, Jul 16, 2020
Acute Ischemic Stroke
N Engl J Med 2020; 383:252-260Treatment for patients with acute ischemic stroke is guided by the time from the onset of stroke, the severity of neurologic deficit, and findings on neuroimaging. Recommended treatments in selected patients include intravenous thrombolysis with alteplase and mechanical thrombectomy.
- EditorialVOL. 383 No. 3, Jul 16, 2020
Antiplatelet Treatment to Prevent Early Recurrent Stroke
N Engl J Med 2020; 383:276-278Without urgent treatment, the risk of major stroke in the week after a transient ischemic attack (TIA) or minor stroke can be as high as 10%.1 Some studies have shown that immediate medical treatment with antiplatelet agents and statins, as well as blood-pressure control, reduces that risk by...
- Original ArticleVOL. 382 No. 24, Jun 11, 2020
Thrombectomy for Stroke in the Public Health Care System of Brazil
N Engl J Med 2020; 382:2316-2326Endovascular thrombectomy has been effective in reducing stroke-related disability in high-income countries. This trial in the public health care system of Brazil, a developing country, showed similar effectiveness in patients treated within 8 hours after the onset of symptoms.
- Original ArticleVOL. 382 No. 21, May 21, 2020
Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke
N Engl J Med 2020; 382:1981-1993In a multicenter Chinese trial involving 656 patients with large-vessel occlusion, endovascular thrombectomy was noninferior, within a 20% margin of confidence, to endovascular thrombectomy with intravenous alteplase given within 4.5 hours after stroke. The incidence of intracerebral hemorrhage was similar in the two groups.
- EditorialVOL. 382 No. 21, May 21, 2020
Thrombolysis before Thrombectomy — To Be or DIRECT-MT?
N Engl J Med 2020; 382:2045-2046Endovascular thrombectomy has been shown to be safe and effective for the treatment of appropriately selected patients with acute ischemic stroke up to 24 hours after symptom onset.1-3 Several trials are attempting to expand the selection criteria for thrombectomy, in the hope of finding additional populations of patients...